Ostomy Wound Management, an official journal of the Association for the Advancement of Wound Care, is a peer-reviewed, multispecialty journal dedicated to informing the practice, advancing the science, and improving the evidence base of all aspects of wound, continence, ostomy, and skin care. Manuscripts that meet this editorial purpose include, but are not limited to:
- reports of preclinical and clinical research studies — eg, randomized, controlled, clinical studies that expand existing knowledge;
- outcomes and comparative effectiveness studies derived from large-scale trials and extant data sets;
- case series and case studies that stimulate research, the exchange of clinical information, describe unusual or rare clinical observations, or reflect a unique approach to patient care;
- indepth reviews of clinical practice, management, prevention, reimbursement, educational, ethical, and legal issues that affect wound, continence, ostomy and skin care;
- literature reviews and reports of contemporary topics in healthcare and healthcare practice that may affect the delivery, reimbursement, or practice of wound, continence, ostomy, or skin care;
- letters to the editor in response to material published in Ostomy Wound Management or addressing a timely and particularly salient issue.
Ostomy Wound Management is indexed in MEDLINE© and the Cumulative Index to Nursing and Allied Health (CINAHL©) and included in the Thomson Reuters Scientific Database and the British Nursing Index. To further meet its editorial purpose and reduce potential barriers to accessing published information, single copies of all published articles (in PDF, HTML format, or both) are available free of charge to all registered users of the Ostomy Wound Management website (www.o-wm.com).
Because the Ostomy Wound Management Editorial Board recognizes the importance of a timely exchange of scientific information, authors usually receive a decision about their manuscript within 8 weeks of submission, and most submissions are published within 3 to 6 months following receipt of the final manuscript (see III).
I. General Manuscript Preparation Guidelines
Ostomy Wound Management editorial policies for authors, reviewers, and editorial staff are based on the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” published by the International Committee of Medical Journal Editors (ICMJE; for complete guidelines, visit: www.icmje.org). Guidelines for authors are based on the American Medical Association (AMA) Manual of Style, 10th edition (see: www.amamanualofstyle.com/oso/public/index.html). Authors of clinical studies, especially randomized controlled trials (RCTs), are encouraged to follow the minimum set of recommendations for reporting the results of their work promulgated by the CONSORT group (see: www.consort-statement.org/consort-statement/overview0/).
A few common concerns: All abbreviations must be spelled out when first used followed by the abbreviation in parenthesis. Similarly, proprietary product name(s) and applicable copyright or trademark information should be included once in the body of the manuscript (not in the title or abstract), followed by the generic name in parentheses, which is then used throughout the remainder of the manuscript.
Before submitting the manuscript, authors are encouraged to contact the Editor by email or phone. In addition, prospective authors may want to discuss their ideas with our clinical editors or Editorial Board members.
II. Preparing the Manuscript
All manuscripts follow the same general format outlined below and are based on the aforementioned AMA guidelines. The generally accepted manuscript length is 18 to 25 typewritten, double-spaced pages (not including tables and figures).
Criteria for authorship, as defined by the ICMJE and adopted by Ostomy Wound Management include:
- substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data;
- drafting the article or revising it critically for important intellectual content;
- final approval of the version to be published. Authors should meet conditions 1, 2, and 3.
All persons who meet the above criteria must be listed as authors. As part of the submission process, authors must indicate whether any writing assistance other than copy editing was provided.
A.1. Student authors
Ostomy Wound Management encourages clinicians advancing their education to submit research and/or studies undertaken during or as part of their coursework. Manuscripts designated “student author” will be accorded leeway in the review process; authors also may request an Editorial Board member mentor to critique and guide manuscript preparation by contacting the Editor. All manuscripts must conform with Ostomy Wound Management style, tone, and level of scientific rigor; referencing and citations must follow American Medical Association format (see II.J). Authors of published student mansucripts become eligible for a Student Author award, presented yearly and free registration to one Symposium on Advanced Wound Care.
The title of the manuscript should convey the health topic (eg, clinical condition, concern) and content (eg, in vivo study, randomized controlled clinical study, literature review).
All manuscripts should be accompanied by a 150- to 200-word abstract containing:
- an introductory statement about the topic and/ or concern;
- purpose of the paper or study;
- method(s) used;
- most salient findings, results, or observations;
The abstract should be followed by three to five keywords. Authors should refer to the MESH vocabulary of the National Library of Medicine to find keywords pertaining to the type of manuscript (eg, study), health condition, and topic. These terms are available at: www.nlm.nih.gov/mesh/MBrowser.html.
D. Introduction and/or Literature Review
The purpose of an introduction and/or literature review is to describe the topic, summarize previous research and existing evidence, and identify relationships, contradictions, gaps, and inconsistencies. Summaries of previous research should use as many primary/original references and sources of information as possible. Secondary information sources (eg, review articles, textbooks) may be appropriate at times but should be identified as review articles, opinions, and the like. Throughout the manuscript, details about pertinent references used must be included to clarify the strength of existing evidence. Study type (eg, in vivo, case series), design (eg, retrospective), sample size, and summary of pertinent results must be included in the text.
E. Study/Publication Purpose
The study/publication purpose and design or hypothesis flows from and concludes the introduction.
F. Methods and Procedures
All methods and procedures must be described in detail, including literature search methods for literature reviews. Institutional Review Board approval and informed consent procedures used must be included for all studies involving patient interventions or use/retrieval of clinical data (see also Ethical considerations). Authors of clinical studies, especially RCTs, should consult and follow the minimum set of recommendations for reporting the results of their work promulgated by the CONSORT group (see: www.consort-statement.org/consort-statement/overview0/). A description of data entry and analysis methods used usually concludes the methods and procedures.
All findings and results of all variables collected and analyzed are described in the text and, if appropriate, presented in tables and figures. Authors should follow AMA guidelines for the use of tables and figures. Figures are usually reserved for showing data patterns. Color photographs also can be helpful for illustrating observations.
Tables, figures, and illustrations should be numerically labeled in the order in which they are cited in the text (eg, “see Figure 1”) and should be labeled clearly. Titles and legends can be printed above, below, or next to the figure or table, or on a separate page following the conclusion. Titles and legends should provide enough detail to make illustrations comprehensible without reference to the text. Illustrations and tables should not be embedded within the text of the Word document submitted.
The discussion section evaluates and interprets the results and observations, especially with respect to the study or project hypothesis or purpose. The most salient findings are highlighted while similarities and differences between the results described and previously published studies and observations are examined. Limitations of the project or study (eg, small sample size, methodological limitations) are also described in the discussion section. Suggestions for future research to answer new or remaining questions as well as potential implications for practice should be described.
The results and examination of earlier research support the conclusion of the paper.
I. Acknowledgment (optional)
Additional contribution of human or financial resources are mentioned here.
References are numbered chronologically as they appear in the text. If a reference is cited multiple times, it is noted using the number of its initial appearance.
References are listed at the end of manuscript and in the numerical order in which they appear in the text. All information needed to identify and retrieve the source must be included. For example:
References to publications in journals, magazines, and other periodicals must include (please note appropriate punctuation): Author name(s) — last name and initials. Title of the article/work. Title of the periodical. Year; volume (issue number):page numbers.
References to book chapters include: Author name(s). Title of the chapter. In: Editor(s) name(s) (ed[s]). Title of the book. Location of publisher: Publisher name; Year: page numbers
Reference to an online source of information: Author name(s). Title of the work. Available at: provide http://site. Accessed month, day, year.
III. Cover Letter and Disclosures
The cover letter should indicate the manuscript title and the corresponding author and provide a complete address, daytime telephone number, fax number, and email address. If the manuscript contains case study or research information, the corresponding author should explain in the cover letter how the rights and dignity of all subjects involved were protected. Photographs will not be published without a signed statement of consent from the subject (or if the patient is a minor, from both parents or the legal guardian). Recently announced Standards for Commercial Support by the Accreditation Council for Continuing Medical Education, coupled with current market dynamics, have influenced the review/disclosure/publication process. Please note that Ostomy Wound Management has and will continue to uphold these standards in its articles.
Financial disclosure. Financial disclosures (ie, potential conflicts of interest) and must be signed by all authors and included in the cover letter or on a separate page.
When no financial support has been, or will be, received: “The author(s) herewith certifies that he/she have no commercial, proprietary, or financial interest in the products or companies described in the manuscript. The author(s) did not receive grants or a consultant honorarium to conduct the study, write the manuscript, or otherwise assist in the development of the above-mentioned manuscript.” When financial support has been received, sponsorship should be acknowledged. For example: “The author(s) herewith certify that he/she has received monetary compensation to… (eg, conduct the study, write the manuscript, lecture for the company producing the products discussed, or similar activity) from… (name of company or organization that provided the grant).”
Ethical considerations. “The author(s) herewith certifies that he/she is responsible for the contents of the manuscript. He/she has complied with the guidelines for conducting research in human subjects (and, if appropriate, FDA guidelines).” Authors submitting results of preclinical research should inform the editor about methods used to adhere to animal welfare regulations.
Disclosure of publication/copyright transfer. “The author(s) herewith certifies that the manuscript has not been submitted for review and publication to any other journal and that the material has been prepared specifically and solely for Ostomy Wound Management.” Or, “The author(s) herewith inform the editors that…(eg, the results of this study were presented at the Symposium on Advanced Wound Care, Miami Beach, FL, 1998 and the abstract published; or, a synopsis of the enclosed manuscript has been distributed during a staff meeting at Mercy General Hospital in May 1998).” “In consideration of the action of the Editors of Ostomy Wound Management in reviewing and editing this submission, the author(s) hereby transfers, assigns, or otherwise conveys all copyright ownership to Ostomy Wound Management in the event that such work is published in Ostomy Wound Management.”
IV. Submission Criteria/Ethical and Legal Considerations
In accordance with AMA, American Psychological Association (APA), and ICMJE guidelines, duplicate or redundant publication of manuscripts is generally unacceptable. Failure to disclose the existence of duplicate articles, manuscripts, or other material is unethical and may represent a violation of copyright law. Exceptions to this rule, providing proper attribution to the report or disclosure of presentation is provided, may include: summaries or abstracts of findings printed in conference proceedings, short reports of author findings distributed at meetings, reports from government documents or reports in the public domain, and translation of reports in another language. Material directly quoted from previously published work can be incorporated in a short quotation (with appropriate attribution). Approval from the copyright holder (institution, publisher, or author) to use more than 40 words or any tables, figures, and photographs from previously published work must be obtained in writing and provided to the Editors. Manuscripts submitted to Ostomy Wound Management are accepted with the understanding that they have not been previously published and are not submitted for review elsewhere.
Upon submission of the manuscript, authors will be asked to sign a statement that the manuscript is original and does not contain substantial amounts of information or data that have been published elsewhere or have been submitted for review and publication elsewhere (journal/book/electronic publication medium). The author(s) also will be asked to sign a copyright transfer, previous presentation/publication information, and financial support disclosure agreement. If the manuscript is not accepted for publication, the copyright transfer agreement will be returned to the author. Manuscripts accepted for publication are copyrighted in the volume and issue published. Materials reproduced without permission from HMP Communications, LLC cannot exceed 50 words.
Following publication of the manuscript, the author (see “corresponding author” under Submission process) will receive five complimentary copies of the issue in which his/her article appears. Authors receive a discount when ordering reprints of their publications.
B. Errors and Misconduct
If an author identifies an error after the manuscript has been published, he/she must contact the Editor as soon as possible and prepare a letter correcting the error(s) for publication in the journal. The Editorial Policy Committee of the Council of Science Editors has identified the following general areas of research misconduct:
- unethical treatment of research subjects;
- fabrication of data;
- falsification of data;
- plagiarism. Plagiarism includes the use of another person’s ideas, processes, results, or words without giving appropriate credit. When a manuscript has been accepted for publication, all authors will be asked to sign a statement related to data integrity, accuracy, and adherence to guidelines for conducting research in humans and animals. If the editors become aware of research misconduct after a manuscript has been published, the editors will contact the authors and notify the readers.
V. Submission Process
Ostomy Wound Management will work with one author (designated the “corresponding author”) who will be responsible for all correspondence regarding submission, review, revision, and acceptance. It is the responsibility of the corresponding author to ensure all deadlines are met and all documents are distributed to additional authors and returned promptly. It is also the author’s responsibility to keep the Editors abreast of his/her reliable contact information.
A. Sending the Manuscript/Materials
All aforementioned manuscript materials are to be submitted using the online Editorial Manager system at: www.edmgr.com/OWM/default.aspx. Authors should select the Author option and follow the online instructions found at this website for uploading the manuscript and all related material.
Questions regarding the submission process can be directed to the Assistant Editor, Ostomy Wound Management, 70 E. Swedesford Road, Suite 100, Malvern, PA 19355; 610-560-0500, extension 4135; or emailed to: firstname.lastname@example.org.
If for any reason the author is unable to submit manuscript materials through the online system, said materials may be submitted to the Editor via email (email@example.com) as Word documents. Tables should appear at the end of the manuscript. Photographs (high-resolution) and figures should not be embedded in the Word document; they should be provided as separate files. All submissions must include: 1) a cover letter, 2) signed financial disclosure and copyright documents and previous publication statement (see III), and 3) a title page. All photos must comply with current HIPAA regulations protecting patient identity.
Persons without access to the Internet should contact the Editor directly (see contact information to follow) for instructions on hard-copy submission. Basically, all aforementioned materials would need to be copied to a CD-ROM and mailed to:
Barbara C. Zeiger, Editor
Ostomy Wound Management
70 E. Swedesford Road, Suite 100
Malvern, PA 19355
(800) 237-7285, ext. 4244 or (610) 560-0500, ext. 4244
VI. The Manuscript Review and Publication Process
All submitted manuscripts go through at least two review cycles. During the first level of review, the manuscript may be forwarded for peer review or the author may receive a letter indicating the manuscript is not accepted for publication or that revisions are needed. The second level (peer) review process involves a minimum of three Editorial Board members from the discipline(s) relevant to the manuscript. The manuscript peer-review process is double-blind; the identity of the author(s) is not revealed to the reviewers. Manuscripts are reviewed for accuracy, their contribution to new knowledge, relevance to the focus of the journal, timeliness, and originality. This part of the review process takes approximately 6 weeks. Author(s) will receive a letter indicating whether the manuscript has been accepted for publication, as well as all reviewer comments and revision requests. If the manuscript is accepted for publication, authors will be asked to return the revised manuscript after approximately 2 to 3 weeks. Manuscripts will not be entered into the publication line-up until the revised manuscript has been received and reviewed.
One month before publication, galley proofs will be provided to the author, who will need to respect a relatively quick turn-around time (2 to 3 business days) to approve the final manuscript and/or make minor changes.
1. American Medical Association. Manual of Style: A Guide for Authors and Editors, 10th ed. Oxford, UK: Oxford University Press;2007.
2. American Psychological Association. Publication Manual of the American Psychological Association, 6th ed. Washington, DC: American Psychological Association;2010.
3. International Committee of Medical Journal Editors. Available at: www.icmje.org/. Accessed July 6, 2017.
4. Editorial Policy Committee (2005-2006), Council of Science Editors. SE’s White paper on promoting integrity in scientific journal publications. Available at: www.CouncilScienceEditors.org. Accessed July 6, 2017.